Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Quell Therapeutics is the world leader in developing engineered T-regulatory (Tregs) cell therapies for serious medical conditions driven by the immune system. Jeito continues to build a strong portfolio of companies with groundbreaking therapies in areas of high...
Find all our press releases
Jeito Capital portfolio company SparingVision announces strategic collaboration with Intellia Therapeutics
Partnership will allow SparingVision to develop novel genomic medicines for the treatment of...
Jeito Capital becomes Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 million ($630 million)
Oversubscribed Jeito I becomes the largest European fund dedicatedto the life sciences sector....
The appointment of Dr. Tordjman was granted by French Ministers, Agnès Pannier-Runacher and...
Jeito Capital becomes key investor in Alentis Therapeutics as part of $67 million Series B financing round
Jeito Capital selects Alentis Therapeutics as its fifth investment since launching the fund...
Jeito selects Pulmocide as its fourth investment since launching the fund Pulmocide is a...
First Year-in-Review: Jeito Capital confirms strength of its investment model and 2021 ambitions with more deals and significant capital
The investment fund confirms the strength of its investment model in medical innovation, closing...
Face to face
All day long
For more than 25 years, BIO-Europe is one of the most influential life sciences trade shows thanks to the synergies it creates in order to bring out medical innovations.
During this event, Sabine Dandigiuan, Managing Partner of Jeito Capital, will participate in the “Talent: finding it, developing it, keeping it” panel.
All day long
HealthTech Innovation Days 2021
Jeito Capital will be Silver Sponsor at HealthTech Innovation Days 2021.
Attend to Rafaèle Tordjman, MD PhD, Keynote on October, 5 at 6.30 PM CET